Pituitary Macroadenoma in a Girl with Male Karyotype: A Rare Case Study

Fatinah Shahab, Tania Tedjo Minuljo, Calvin Layuk Allo, Dody Priambada, Mahayu Dewi Ariani, Sultana Faradz


Macroadenoma is a tumor that typically develops in the epithelial cells of the pituitary gland. Patients suffering from the condition are often asymptomatic with complaints that are caused by hormonal imbalance. Therefore, chromosome analysis needs to be done to females aged >16 years presenting with amenorrhea. Karyotype 46,XY is a disorder of sex development (DSD) that is caused by the complex process of gene interactions, androgen synthesis, and hormone regulation.
The patient initially came to the hospital for a scheduled transsphenoidal surgery due to pituitary macroadenoma, and later complained of primary amenorrhea and atypical external genital. Furthermore, physical examination of genitalia revealed mild clitoromegaly without obvious introitus vagina. Laboratory testing showed elevated prolactin and testosterone level, while ultrasonography imaging revealed the absence of the uterus and ovaries. The brain magnetic resonance imaging (MRI) demonstrated a pituitary adenoma, and cytogenetic analysis showed 46,XY karyotype. Subsequently, hyperprolactinemia, imaging, and histopathology examination were used to confirm pituitary macroadenoma in the patient. It was assumed that the undermasculinized genitalia was caused by hormonal disorders including the deficiency of androgen action or 5-alpha-reductase enzyme. 46,XY DSD has many different symptoms, hence, clinicians need to be aware of potential multifactorial aetiologies. Imaging of internal genitalia, hormonal and chromosomal analysis should be carried out to assess patients with unknown causes of the disorder. Molecular analysis needs to be carried to exclude the possible gene mutation.


Disorder of sex development (DSD); primary amenorrhea; pituitary macroadenoma


Hughes IA, Houk C, Ahmed SF, Lee PA, Group LEC. Consensus statement on management of intersex disorders. Arch Dis Child. 2006;91:554-63.

Nordenström A. Puberty in individuals with a disorder of sex development. Current Opinion in Endocrine and Metabolic Research. 2020;14:42-51.

Cools M, Drop SL, Wolffenbuttel KP, Oosterhuis JW, Looijenga LH. Germ cell tumors in the intersex gonad: old paths, new directions, moving frontiers. Endocr Rev. 2006;27(5):468-84.

Wisniewski AB, Mazur T. 46, XY DSD with female or ambiguous external genitalia at birth due to androgen insensitivity syndrome, 5α-reductase-2 deficiency, or 17β-hydroxysteroid dehydrogenase deficiency: A review of quality of life outcomes. Int J Pediatr Endocrinol. 2009;2009:1-7.

Mendonca BB, Domenice S, Arnhold IJ, Costa EM. 46,XY disorders of sex development (DSD). Clin Endocrinol (Oxf). 2009;70(2):173-87.

Kadhim MM, Aboud MJ. Disorders of sex development: Molecular versus clinical and cytogenetic studies and their correlation with diagnostic outcome and sex of rearing in a local community. JMSCR. 2014;2(7):1626-46.

Khanna K, Sharma S, Gupta DK. A clinical approach to diagnosis of ambiguous genitalia. J Indian Assoc Pediatr Surg. 2019;24(3):162-9.

Brain CE, Creighton SM, Mushtaq I, et al. Holistic management of DSD. Best Pract Res Clin Endocrinol Metab. 2010;24(2):335-54.

Listyasari NA, Santosa A, Juniarto AZ, Faradz SMH. Multidisciplinary management of disorders of sex development in Indonesia, a prototype in developing country. Journal of Biomedicine and Translational Research. 2017;3(1).

R K, I M, M E, M M, A E. Genetic and clinical study of disorder of sex development among children and adolecents. Life Science Journal. 2020;17(6).

öcal G. Current concepts in disorders of sex development. J Clin Res Ped Endo 2011;3(3):105-14.

Wisniewski AB. Gender development in 46,XY DSD: Influences of chromosomes, hormones, and interactions with parents and healthcare professionals. Scientifica (Cairo). 2012;2012:834967.

Wisniewski AB, Batista RL, Costa EMF, et al. Management of 46,XY differences/disorders of sex development (DSD) throughout life. Endocr Rev. 2019;40(6):1547-72.

Jung EJ, Im DH, Park YH, et al. Female with 46, XY karyotype. Obstet Gynecol Sci. 2017;60(4):378-82.

Ahmed SF, Bashamboo A, Lucas-Herald A, McElreavey K. Understanding the genetic aetiology in patients with XY DSD. Br Med Bull. 2013;106:67-89.

Homa L, Thomas S, Sanfilippo J. Primary amenorrhea with transverse vaginal septum and scant hematocolpos: A case report. Open J Pediatrics. 2012;02(01):87-91.

Rutkowski MJ, Alward RM, Chen R, et al. Atypical pituitary adenoma: a clinicopathologic case series. J Neurosurg. 2018;128(4):1058-65.

Jang MK, Oh EG, Lee H, Kim EH, Kim S. Postoperative symptoms and quality of life in pituitary macroadenomas patients. Journal of Neuroscience Nursing. 2020;52(1):30-6.

Maleki N, Kalantar Hormozi M, Iranparvar Alamdari M, Tavosi Z. 5-alpha-reductase 2 deficiency in a woman with primary amenorrhea. Case Rep Endocrinol. 2013;2013:631060.

Berra M, Williams EL, Muroni B, et al. Recognition of 5alpha-reductase-2 deficiency in an adult female 46XY DSD clinic. Eur J Endocrinol. 2011;164(6):1019-25.

Campbell IM, Yuan B, Robberecht C, et al. Parental somatic mosaicism is underrecognized and influences recurrence risk of genomic disorders. Am J Hum Genet. 2014;95(2):173-82.

Parisi MA, Ramsdell LA, Burns MW, et al. A Gender Assesstment Team: experience with 250 patients over a period of 25 years. Genet Med 2007;9(6):348-57.

Moshiri M, Chapman T, Fechner PY, et al. Evaluation and management of disorder of sex development : Multidisciplinary approach to complecx diagnosis. . radiographicsrsnaorg. 2012;32(6):1599-618.

Hummadi AA, Yahya AO, Al-Qahtani AM. Late diagnosis of 5-alpha-reductase type 2 deficiency in an adolescent girl with primary amenorrhoea. Sultan Qaboos Univ Med J. 2017;17(2):e218-e20.

Lanciotti L, Cofini M, Leonardi A, Bertozzi M, Penta L, Esposito S. Different clinical presentations and management in complete androgen insensitivity syndrome (CAIS). Int J Environ Res Public Health. 2019;16(7).

Tortosa F, Webb SM. Novel aspects in histopathology of the pituitary gland. Endocrinología, Diabetes y Nutrición (English ed). 2017;64(3):152-61.

Vilar L, Vilar Clarice F, Lyra R, Freitas Maria da C. Pitfalls in the diagnostic evaluation of hyperprolactinemia. Neuroendocrinology. 2019;109(1):7-19.

Qari FA, AbuDaood EA, Nasser TA. Diabetes insipidus following neurosurgery at a university hospital in Western Saudi Arabia. Saudi Med J. 2016;37(2):156-60.

de Vries F, Lobatto DJ, Verstegen MJT, van Furth WR, Pereira AM, Biermasz NR. Postoperative diabetes insipidus: how to define and grade this complication? Pituitary. 2021;24(2):284-91.

Looijenga LH, Hersmus R, Oosterhuis JW, Cools M, Drop SL, Wolffenbuttel KP. Tumor risk in disorders of sex development (DSD). Best Pract Res Clin Endocrinol Metab. 2007;21(3):480-95.

Full Text: PDF


  • There are currently no refbacks.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.